Methods and systems for background processing for covalent binding determination

The method of ionizing target molecules with and without ligands, calculating intensity ratios, and subtracting background noise in mass spectrometry accurately assesses covalent binding, addressing the challenge of background noise interference and enhancing the reliability of covalent binding determination.

WO2024246845A1PCT designated stage expired Publication Date: 2024-12-05DH TECH DEVMENT PTE
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
PCT/IB2024/055323
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-06-01
Filing Date
2024-05-31
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Mass spectrometry struggles to distinguish covalent binding signals from background noise in deconvoluted mass spectra, leading to false positives or negatives, especially when the signal-to-noise ratio is low and background intensity is significant.

Method used

A method involving ionizing a target molecule with and without a ligand, generating deconvoluted mass spectra, determining intensity ratios to subtract background noise, and calculating background-subtracted signal intensities to accurately assess covalent binding, using equations like PLi = (PLobs,i - Ri*Pi)/(1+Ri) for single ligand molecules and adjusting for multiple ligand molecules.

Benefits of technology

This approach effectively differentiates covalent binding signals from background noise, improving the accuracy of covalent binding determination and reducing false positives/negatives by providing a clear threshold comparison for determining covalent bonding.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IB2024055323_05122024_PF_FP_ABST
    Figure IB2024055323_05122024_PF_FP_ABST
Patent Text Reader

Abstract

Methods and systems for background processing include ionizing a first sample and a second sample, the first sample including the target molecule, and the second sample including a target molecule-ligand combination, capturing a raw mass spectrum for the ionized first sample and second sample, generating a deconvoluted mass spectrum for the first sample and the second sample, determining an intensity ratio of a background intensity at a mass window corresponding to a sum of a mass of the target molecule and a mass of the ligand in the first sample to a signal intensity at a mass window corresponding to the target molecule in the first sample, and determining, based on the determined intensity ratio, a background intensity of the target molecule- ligand combination in the deconvoluted mass spectrum of the second sample at a mass window corresponding to the mass of the target molecule-ligand combination.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] 18768.0083 W0U1 / ABS-0762PCT

[0002] METHODS AND SYSTEMS FOR BACKGROUND PROCESSING FOR COVALENT BINDING DETERMINATION

[0003] CROSS-REFERENCE TO RELATED APPLICATION

[0004] This application claims the benefit of U.S. Provisional Application No. 63 / 505,525 filed June 1, 2023, the disclosure of which is hereby incorporated by reference in its entirety.

[0005] BACKGROUND

[0006] Identifications of covalent modifiers of an enzyme, protein or nucleic acid are useful tools for use in the development of novel drugs, and mass spectrometry is used to screen such covalent interaction between a target molecule and small molecules. Mass spectrometry is used to determine whether a compound is covalently bonded to a target protein by measuring the intact mass of the modified protein. Due to the existence of background noise in a deconvoluted mass spectrum, it may be challenging to distinguish the signal of the enzyme, protein, or nucleic acid from the background noise.

[0007] SUMMARY

[0008] In one aspect of the present disclosure, a method for background processing of a deconvoluted mass spectrum for a collection of samples includes ionizing a first sample and a second sample of a same target molecule, the first sample including the target molecule in the absence of a ligand “i”, and the second sample including a target molecule-ligand “i” combination, capturing a raw mass spectrum for each of the ionized first sample and the ionized second sample, generating a deconvoluted mass spectrum for each of the first sample and the second sample based on their respective captured raw mass spectrum, determining, based on the generated deconvoluted mass spectrum of the first sample, an intensity ratio R of a background intensity B at a mass window of the deconvoluted mass spectrum corresponding to a sum of a mass of the target molecule and a mass of the ligand “i” in the first sample to a signal intensity P at a mass window corresponding to the target molecule in the first sample, and

[0009] 1 determining, based on the determined intensity ratio R, a background intensity Bi of the target molecule-ligand “i” combination in the deconvoluted mass spectrum of the second sample at a mass window corresponding to the mass of the target moleculeligand “i” combination.

[0010] In an example of the above aspect, the determined intensity ratio R of the first sample is equal to a ratio of the background intensity Bi to a sum of the signal intensity Pi at the mass window corresponding to the target molecule in the second sample and a signal intensity PLi of the target molecule-ligand “i” combination at the mass window corresponding to the sum of the mass of the target molecule and the mass of the ligand in the second sample. For example, B / P = Bi / (Pi+PLi). In a further example, the method further includes determining, based on the determined background intensity Bi of the second sample, the background-subtracted signal intensity PLi of the target molecule-ligand “i” combination in the second sample. In yet another example, determining the background-subtracted signal intensity PLi includes determining an observed signal intensity PLobs,i of the target molecule-ligand “i” combination in the second sample, and subtracting the determined background intensity Bi from the observed signal intensity PLobs,i. For example, the signal intensity PLi is equal to PLi = (PLobs,i - Ri*Pi) / (l+Ri). In a further example, the method further includes comparing a ratio PLi / Pi to a threshold, and based on the comparison, determining whether the ligand and the target molecule are covalently bonded. For example, the threshold is in a range of 10% to 30%.

[0011] In an additional example of the above aspect, the signal intensity PLi of the ligand “i” in the second sample is equal to PLi = (PLobs,i - RiPi). In an example, the method further includes comparing a ratio PLi / Pi to a threshold, and based on the comparison, determining whether the ligand and the target molecule are covalently bonded. In another example, the second sample includes the target molecule bonded to “k” molecules of the ligand “i”. For example, a signal intensity PLik of “k” molecules of ligand “i” combined with the target molecule in the second sample is equal to PLik = (PLobs,ik - RikPi) / (l+Rik); where PLobs,ik is an observed signal intensity of “k” molecules of ligand “i” combined with the target molecule in the second sample, Pi is a signal intensity of the target molecule in the second sample, and Rik is an intensity ratio for ligand “i” in the second sample. In a further example, a signal intensity PLik of “k” molecules of ligand “i” combined with the target molecule in the second sample is equal to PLik = (PLobs,ik - RikPi); where PLobs,ik is an observed signal intensity of “k” molecules of ligand “i” combined with the target molecule in the second sample, Pi is a signal intensity of the target molecule in the second sample, and Rik is an intensity ratio for ligand “i” in the second sample. In yet another example, k is in a range of 1 to 5.

[0012] In yet a further example, when k is equal to 3, intensity signals of each combination of target molecule and ligand are calculated as PLil = (PLobsil*(l+Ri2+Ri3) - Ril(PLobs,i2 + PLobs,i3+Pi)) / (l+Ril+Ri2+Ri3), PLi2 = (PLobsi2*(l+Ril+Ri3) - Ri2(PLobs,il + PLobs,i3+Pi)) / (l+Ril+Ri2+Ri3), and PLi3 = (PLobs,i3*(l+Ril+Ri2) - R3(PLobs,il + PLobs,i2+Pi)) / (l+Ril+Ri2+Ri3), wherein PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively, PLobsi,l, PLobsi,2 and PLobsi,3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i” , respectively, Pi is a signal intensity of the target molecule, and Ril, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively.

[0013] In an additional example, when k is equal to 3, the intensity signals of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively, are calculated as PLil = PLobs,il - Ril(PLobsi,2 + PLobsi,3+Pi), PLi2 = PLobs,i2 - Ri2(PLobsi,l + PLobsi,3+Pi), and PLi3 = PLobs,i3 - Ri3(PLobsi,l + PLobsi,2+Pi), PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively, PLobsi,l, PLobsi,2 and PLobsi,3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively, Pi is a signal intensity of the target molecule, and Ril, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively. In a further example, the method further includes comparing PLi,k ZPi to a threshold, and based on the comparison, determining whether the k molecules of ligand “i” and the target molecule are covalently bonded. In an example, the target molecule includes one of a protein, an enzyme, and a nucleic acid.

[0014] In another aspect of the present disclosure, a sample analyzing system includes a sample ionization device a sample receiver, a mass analysis device fluidically coupled to the sample receiver and to the sample ionization device, a processor operatively coupled to the sample receiver, the sample ionization device and to the mass analysis device, and a memory coupled to the processor, the memory storing instructions that, when executed by the processor, perform a set of operations. For example, the set of operations include ionizing, via the sample ionization device, a first sample and a second sample of a same target molecule, the first sample including the target molecule in the absence of a ligand “i”, and the second sample including a target molecule-ligand “i” combination, capturing, via the mass analysis device, a raw mass spectrum for each of the ionized first sample and the ionized second sample, generating, via the processor, a deconvoluted mass spectrum for each of the first sample and the second sample based on their respective captured raw mass spectrum, determining, via the processor, based on the generated deconvoluted mass spectrum of the first sample, an intensity ratio R of a background intensity B at a mass window of the deconvoluted mass spectrum corresponding to a sum of a mass of the target molecule and a mass of the ligand “i” in the first sample to a signal intensity P at a mass window corresponding to the target molecule in the first sample, and determining, via the processor, based on the determined intensity ratio R, a background intensity Bi of the target molecule-ligand “i” combination in the deconvoluted mass spectrum of the second sample at a mass window corresponding to the mass of the target molecule-ligand “i” combination.

[0015] In another example, the determined intensity ratio R of the first sample is equal to a ratio of the background intensity Bi to a sum of the signal intensity Pi at the mass window corresponding to the target molecule in the second sample and a signal intensity PLi of the target molecule-ligand “i” combination at the mass window corresponding to the sum of the mass of the target molecule and the mass of the ligand in the second sample. For example, B / P = Bi / (Pi+PLi).In a further example, the set of instructions further includes determining, based on the determined background intensity Bi of the second sample, the background-subtracted signal intensity PLi of the target molecule-ligand “i” combination in the second sample. In yet another example, the set of instructions further includes determining the background-subtracted signal intensity PLi by determining an observed signal intensity PLobs,i of the target molecule-ligand “i” combination in the second sample, and subtracting the determined background intensity Bi from the observed signal intensity PLobs,i. In yet a further example, the signal intensity PLi is equal to PLi = (PLobs,i - Ri*Pi) / (l+Ri). In an additional example, the set of instructions further includes comparing a ratio PLi / Pi to a threshold, and based on the comparison, determining whether the ligand and the target molecule are covalently bonded. For example, the threshold is in a range of 10% to 30%.

[0016] In another example, the signal intensity PLi of the ligand “i” in the second sample is equal to PLi = (PLobs,i - RiPi). In a further example, the set of instructions further includes comparing a ratio PLi / Pi to a threshold, and based on the comparison, determining whether the ligand and the target molecule are covalently bonded. In yet another example, the second sample includes the target molecule bonded to “k” molecules of the ligand “i”. In yet a further example, a signal intensity PLik of “k” molecules of ligand “i” combined with the target molecule in the second sample is equal to PLik = (PLobs,ik - RikPi) / (l+Rik); where PLobs,ik is an observed signal intensity of “k” molecules of ligand “i” combined with the target molecule in the second sample, Pi is a signal intensity of the target molecule in the second sample, and Rik is an intensity ratio for ligand “i” in the second sample. In an additional example, a signal intensity PLik of “k” molecules of ligand “i” combined with the target molecule in the second sample is equal to PLik = (PLobs,ik - RikPi); where PLobs,ik is an observed signal intensity of “k” molecules of ligand “i” combined with the target molecule in the second sample, Pi is a signal intensity of the target molecule in the second sample, and Rik is an intensity ratio for ligand “i” in the second sample.

[0017] In an example, when k is equal to 3, intensity signals of each combination of target molecule and ligand are calculated as PLil = (PLobs,il*(l+Ri2+Ri3) - Ril(PLobs,i2 + PLobs,i3+P)) / (l+Ril+Ri2+Ri3), PLi2 = (PLobs,i2*(l+Ril+Ri3) - Ri2(PLobs,il + PLobs,i3+P)) / (l+Ril+Ri2+Ri3), and PLi3 = (PLobs,i3*(l+Ril+Ri2) - Ri3(PLobs,il + PLobs,i2+P)) / (l+Ril+Ri2+Ri3), PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively, PLobs,il, PLobs,i2 and PLobs,i3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively, Pi is a signal intensity of the target molecule, and Ril, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively. In another example, when k is equal to 3, the intensity signals the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively, are calculated as PLil = PLobs,il - Ril(PLobs,i2 + PLobs,i3+Pi), PLi2 = PLobs,i2 - Ri2(PLobs,il + PLobs,i3+iP), and PLi3 = PLobs,i3 - Ri3(PLobs,il + PLobs,i2+Pi), wherein PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively, PLobs,il, PLobs,i2 and PLobs,i3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively, Pi is a signal intensity of the target molecule, and Ril, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively.

[0018] In a further example, the set of instructions further includes comparing PLi,k / Pi to a threshold, and based on the comparison, determining whether the kth molecule of ligand “i” and the target molecule are covalently bonded.

[0019] In an additional example, the sample source is a well plate that includes a plurality of wells, and each sample is in one of the plurality of wells. In another example, the mass analysis device includes at least one of a differential mobility spectrometer (DMS), a mass spectrometer (MS), and a DMS / MS. In a further example, the sample ionization device includes one of a desorption electro-spray ionization (DESI) device, a matrix-assisted laser desorption ionization (MALDI) device, a liquid- atmospheric pressure (LAP)-MALDI device, a rapid-fire mass spectrometer, a pneumatic electrospray ionization (ESI) device, and an electron ionization (El) device.

[0020] The details of one or more techniques are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of these techniques is apparent from the description, drawings, and claims.

[0021] BRIEF DESCRITION OF THE DRAWINGS

[0022] FIG. 1 is schematic diagram illustrating one exemplary mass analysis system in accordance with various aspects and examples of the present disclosure.

[0023] FIG. 2 is schematic diagram illustrating another exemplary mass analysis system in accordance with various aspects and examples of the present disclosure.

[0024] FIG. 3 is a schematic diagram illustrating one example of the centralized control system in accordance with various aspects and examples of the present disclosure.

[0025] FIG. 4 is a schematic diagram illustrating one particular example of the computing device in accordance with various aspects and examples of the present disclosure. FIG. 5 depicts a schematic view of an example system combining an acoustic droplet ejection system with a sampling interface and an ion source.

[0026] FIGS. 6A-6C are illustrations of mass spectra for protein-only samples and protein and ligand samples, in accordance with various examples of the present disclosure.

[0027] FIG. 7 represents a flowchart illustrating a method for automatic background processing of a deconvoluted mass spectrum, in accordance with various examples of the disclosure.

[0028] Before one or more examples of the present teachings are described in detail, one skilled in the art will appreciate that the present teachings are not limited in their application to the details of construction, the arrangements of components, and the arrangement of steps set forth in the following detailed description or illustrated in the drawings. Also, it is to be understood that the terminology used herein is for the purpose of description and should not be regarded as limiting.

[0029] DETAILED DESCRIPTION

[0030] Selected definitions

[0031] For the purposes of interpreting this specification, the following definitions will apply and whenever appropriate, terms used in the singular will also include the plural and vice versa. The definitions set forth below shall supersede any conflicting definitions in any documents incorporated herein by reference.

[0032] As used herein, the singular forms “a,” “an,” and “the,” include both singular and plural referents unless the context clearly dictates otherwise.

[0033] The terms “comprising,” “comprises,” and “comprised of’ as used herein are synonymous with “including,” “includes,” or “containing,” “contains,” and are inclusive or open-ended and do not exclude additional, non-recited members, elements, or method steps. It is appreciated that the terms “comprising,” “comprises,” and “comprised of’ as used herein comprise the terms “consisting of,” “consists,” and “consists of.”

[0034] The recitation of numerical ranges by endpoints includes all numbers and fractions subsumed within the respective ranges, as well as the recited endpoints.

[0035] Whereas the terms “one or more” or “at least one”, such as one or more or at least one member(s) of a group of members, is clear per se, by means of further exemplification, the term encompasses inter alia a reference to any one of said members, or to any two or more of said members, such as, e.g., any >3, >4, >5, >6, or >7, etc. of said members, and up to all said members.

[0036] Unless otherwise defined, all terms used in the present disclosure, including technical and scientific terms, have the meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. By means of further guidance, term definitions are included to better appreciate the teaching of the present disclosure.

[0037] As used herein, an “isotope cluster” or “isotope pattern” or “m / z isotope pattern” or “isotopic distribution” refers to a grouping of intensity peaks associated with a single compound or an ionized species, where the compound or the ionized species that forms the isotope cluster can be isotopically enriched. The isotope cluster can include a single main peak (or main isotope peak) and two or more isotope peaks. The isotope peaks are generally of lower intensity than the main isotope peak, and can be both down-mass and up-mass of the main isotope peak. Although the separation between the main peak and isotope peaks can be measured in whole numbers, for example, 1, 2, 3, etc. Daltons 20 (“Da”), the separation may also be measured as nonwhole numbers, for example, 0.5, 1.2, etc. For example, an isotope cluster with a main peak at “X” Da can include the intensity contribution of one or more additional peaks, e.g., at “X+l” Da, “X+2” Da, and the like.

[0038] As used herein, “intensity” refers to the height of, or area under, a MS peak. For example, the peak can be output data from a measurement occurring in a mass spectrometer (e.g., as a mass-to-charge ratio (m / z)). The charge “z” represents a charge state of the isotope cluster. The value of the charge state can be any positive or negative integer, such as +1, +2, +3, or -1, -2, or -3. In accordance with some examples of the present disclosure, intensity information can be presented as a maximum height of the summary peak or a maximum area under the summary peak representing a m / z value.

[0039] In the following passages, different aspects of the present disclosure are defined in more detail. Each aspect so defined may be combined with any other aspect or aspects unless clearly indicated to the contrary.

[0040] Reference throughout this specification to “one example” or “an example” means that a particular feature, structure, or characteristic described in connection with the example is included in at least one example of the present disclosure. Thus, appearances of the phrases “in one example” or “in an example” in various places throughout this specification are not necessarily all referring to the same example, but may. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner, as would be apparent to a person skilled in the art from this disclosure, in one or more examples. Furthermore, while some examples described herein include some, but not other features included in other examples, combinations of features of different examples are meant to be within the scope of the disclosure, and form different examples, as would be understood by those in the art. For example, in the appended claims, any of the claimed examples can be used in any combination.

[0041] In the present disclosure, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration only of specific examples in which the present disclosure may be practiced. It is to be understood that other examples may be utilized, and structural or logical changes may be made without departing from the scope of the present disclosure. The following detailed description, therefore, is not to be taken in a limiting sense, and the scope of the present disclosure is defined by the appended claims.

[0042] Ionization devices

[0043] Although the sample ionization process is described above in the context of acoustic ejection mass spectrometry (AEMS) using ESI, other techniques of generating ionized samples may be used according to various examples of this disclosure. For example, ionized samples may be generated by DESI, which is a combination of ESI and desorption ionization (DI) methods. In DESI, ionization takes place by directing an electrically charged mist to the sample surface that is a few millimeters away. The electrospray mist is pneumatically directed at the sample, thus forming splashed droplets that carry desorbed, ionized analytes. After ionization, the ions travel through air into the atmospheric pressure interface which is connected to the mass spectrometer.

[0044] Another ionization technique may include MALDI, which is an ionization technique that uses a laser energy absorbing matrix to create ions from large molecules with minimal fragmentation. In MALDI, a laser is fired at the matrix crystals in the dried-droplet spot. The matrix absorbs the laser energy; the matrix is desorbed and ionized (by addition of a proton) by this event. The hot plume produced during ablation contains many species: neutral and ionized matrix molecules, protonated and deprotonated matrix molecules, matrix clusters and nanodroplets.

[0045] Other ionization techniques may include rapid-fire mass spectrometry, LAP- MALDI, pneumatic ESI (which generates ions for mass spectrometry using electrospray by applying a high voltage to a liquid to produce an aerosol), and EL El may also be referred to as electron impact ionization or electron bombardment ionization and is an ionization method in which energetic electrons interact with solid or gas phase atoms or molecules to produce ions. Any of the above techniques, as well as others that can perform sample ionization, may be used in examples of this disclosure.

[0046] System for mass analysis

[0047] High throughput mass spectrometry (MS) analysis for a sample pool or collection containing hundreds or thousands of samples may generate a single MS dataset that includes a large compilation of sub-datasets with respect to each individual sample. In many situations, the samples in a high throughput MS analysis are analyzed successively without interruption, and the resultant single large MS dataset is unsplit and unprocessed. Efficiently processing the last dataset may be advantageous. Subsequently processing the single large dataset is not only time-consuming but may sometimes be a bottleneck for the overall productivity of sample analysis. In addition, data processing for high throughput MS analysis may be technically challenging. Due to the large quantity of data, any deficiency in data processing may be detrimental to the accuracy of analyte identification and / or to the confidence of the analytical results.

[0048] Examples of the present disclosure generally relate to high throughput systems and methods for analyzing a collection of substance samples using mass spectrometry. Conventionally, the preparation and introduction of sample into a mass spectrometer is a relatively time-consuming process, particularly where rapid and efficient analysis of a sample pool containing multiple samples is desired. For instance, multiple different systems may have been used that were provided and controlled by separate entities and / or devices. For example, a liquid handling system would be used for preparation of samples, an ejection system would be used for ejecting samples into a port or interface, and mass spectrometry system would be used for the actual analysis of the samples. Each system needs to be separately controlled and operated, which lead to significant challenges and inefficiencies, including requirement of manual interaction and intervention for many of the operations.

[0049] The systems provided in the present disclosure advantageously include a central control system that is able to control the underlying subsystems used in the sample analysis process. For example, a script or set of operations may be generated at the central control system or controller that allows for control of the subsystems such that the subsystems are able to work synchronously across different types of operations performed by each of the subsystems. To accomplish such synchronicity across the subsystems, additional mechanical devices, such as robotics, may be incorporated into the overall system to handle transitions of materials between the systems. Thus, the central controller is able to interface with the various subsystems and transition robotics to more efficiently control each of the operations performed by the subsystems. Furthermore, the present systems advantageously include a computing subsystem and various functional modules thereof configured to efficiently process the data generated from multiple samples, reliably determine the data-sample correlation for a large pool of samples, generate mass spectra for each test sample, analyze the generated mass spectra, and provide real-time feedback to other subsystems. As a result, the efficiency and productivity of the entire system may be improved.

[0050] Background Processing to Determine Covalent Binding in a Target Biomolecule

[0051] Targeted covalent inhibitors are currently used in the development of novel drugs, due to the high selectivity and improved potency of these drugs. Mass spectrometry has been used to screen such covalent interaction between the target biomolecule and small molecules, the small molecules being, e.g., drug molecules. In examples, when using AEMS, which includes the use of an ESI-based high-throughput MS technology, the sample readout speed (1-sec-per-sample or faster) is significantly faster than, e.g., LC-MS and other current technology that also use ESI-based high- throughput MS technology. When using AEMS compared to other non-ESI-based high- throughput MS technology, the data quality if higher. The ESI-MS based analysis provides adequate quantitative performance that covers a wide chemical space including for an intact protein. In various examples of this disclosure, AEMS based high-throughput platform and its automated data processing workflow may be used to identify, e.g., the covalent binder of a target molecule, the covalent binder being, e.g. a drug molecule, in faster times. In an example, the target molecule may be a protein, an enzyme, or a nucleic acid.

[0052] In various examples, the small molecules such as, e.g., drug molecules, and the target molecule are mixed together and incubated in an assay buffer. During incubation, a protein-compound complex sample may be formed by covalent binding. The sample may be analyzed by, e.g., an AEMS with high throughput readout. In various examples, the mass spectra of each sample, which measures the signal intensity with respect to mass-to-charge ratio (m / z), may be deconvoluted to reconstruct the mass by converting the signal from the m / z scale to the mass scale. In various examples, each signal peak may include multiple data points corresponding to multiple mass spectra cycles, and the information to be used for mass deconvolution may be the average or the sum of all the data points, or of a selective single or several data points. In another example, the mass spectra may also be processed via background subtraction before deconvolution of the extracted mass spectra. However, a technical problem may occur in the presence of background noise that may alter the measurements. Better background processing may thus be advantageous as a solution to the above technical problem.

[0053] Since the identification of the covalent modifier relies on the ratio of the protein-ligand complex vs the total protein in the deconvoluted mass spectrum, it is advantageous to differentiate the signal contributed by the protein-ligand complex from the background noise to avoid false positives when the background intensity is high at the protein-ligand mass range of the deconvoluted mass spectrum and / or false negatives when the background intensity is low and the threshold is high at the protein-ligand mass range. It is more relevant when the protein deconvoluted mass spectrum intensity is not high (e.g., when the signal-to-noise ratio S / N is low) and the background contribution is more significant.

[0054] There are multiple approaches currently used to process the background signal in a deconvoluted mass spectrum. One approach is to obtain the background signal from the non-ejection period and subtract this signal before and / or after the step of mass deconvolution. However, most background due to the sample itself or from the sample matrix which is not present in the non-ejection period cannot be effectively removed with this method. Another approach is to use a reference sample for the background signal generation, and subtract it from the screening sample data. However, it is challenging to identify the ideal sample as the reference of blank sample. In addition, the absolute intensity level may vary between blank and real screening samples. Accordingly, a technical solution to the above technical problem may include determining a background on the deconvoluted mass spectrum of a protein that is unbonded to a ligand, where no ligand is added to the sample, at the mass window that corresponds to the protein-ligand complex, and use that background to determine a background-subtracted signal intensity attributable only to the protein-ligand complex in the deconvoluted mass spectrum of the protein-ligand complex. Now referring to FIGS. 1 and 2, examples of the present disclosure are illustrated and described. The descriptions of FIGS. 1 and 2 are concurrent unless otherwise noted. In the illustrated examples, the system 10 or 10’ can each include, in various combinations, pluralities of components, including some or all of: a mass capture and analysis system 100, a sample preparation system 101, an ejector system 102, a computing system 103, a network 104, a database / library 106, and a remote computing device 108. In the example illustrated in FIG. 1, various systems 100, 101, 102, 103, 104, and 106 are subsystems of the system 10 and may be operably connected between or among each other. For example, the computing system 103 is in bilateral communication with the mass capture and analysis system 100, and is also in bilateral communication with the ejector system 102; the sample preparation system 101 is in communication with the mass capture and analysis system 100, and is also in communication with the ejector system 102; the mass capture and analysis system 100 is in communication with the ejector system 102; and the database 106 and the remote computing device 108 are each in communication with the computing system 103.

[0055] In some examples, the mass capture and analysis system 100 may be a mass analysis instrument 100. The mass capture and analysis system 100 may be a mass spectrometer system including a mass analyzer 120 for analyzing ions generated from ionization of a sample. The mass capture and analysis system 100 may also include a capture device or probe 105 that captures the sample and provides the sample to other components of the mass capture and analysis system 100. In other examples (such as shown in FIG. 2), the capture probe 105 may be located externally from the mass analysis instrument 100. For instance, the capture probe 105 may be part of the ejection system 102.

[0056] It will also be appreciated by a person skilled in the art and in light of the teachings herein that the mass analyzer 120 can have a variety of configurations. Generally, the mass analyzer 120 is configured to process (e.g., filter, sort, dissociate, detect, etc.) sample ions generated by the ion source 115. By way of non-limiting example, the mass analyzer 120 can be a triple quadrupole mass spectrometer, or any other mass analyzer known in the art and modified in accordance with the teachings herein. Other non-limiting, exemplary mass spectrometer systems that can be modified in accordance with various aspects of the systems, devices, and methods disclosed herein can be found, for example, in an article entitled “Product ion scanning using a Q-q-Q linear ion trap (Q TRAP) mass spectrometer” (James W. Hager and J. C. Yves Le Blanc; Rapid Communications in Mass Spectrometry; 2003; 17: 1056-1064); and U.S. Pat. No. 7,923,681, the disclosures of which are hereby incorporated by reference herein in their entireties.

[0057] Other configurations, including but not limited to those described herein and others known to those skilled in the art, can also be utilized in conjunction with the systems, devices, and methods disclosed herein. For instance, other suitable mass spectrometers include single quadrupole, triple quadrupole, time-of-flight (ToF), trap, and hybrid analyzers. It will further be appreciated that any number of additional elements can be included in the system 100 including, for example, an ion mobility spectrometer (e.g., a differential mobility spectrometer) that is disposed between the ionization source 115 and the mass analyzer detector 120 and is configured to separate ions based on their mobility difference between in high-field and low-field). Additionally, it is appreciated that the mass analyzer 120 can include a detector 126 that can detect the ions that pass through the analyzer 120 and can, for example, supply a signal indicative of the number of ions per second that are detected.

[0058] The sample preparation system 101 may include a sample source 70 and a sample handler 80. The sample source 70 and a sample handler 80 are operative to retrieve collections of samples from the sample source(s) and to deliver the retrieved collections to capture locations associated with sample capture probes 105. The systems may be operative to independently capture selected ones of the pluralities of samples at the capture locations from the pluralities of samples, to optionally dilute the samples and to transfer the captured samples to mass analysis instruments 100, 120 for mass analysis. In some examples, the sample source 70 may include a set of well plates in a storage housing and / or liquid for adding to well plates. The sample source 70 may include part of a liquid handling system that manipulates and / or injects liquid into the well plates. The sample handler 80 includes one or more electro-mechanical devices (e.g., robotics, conveyor belts, stages, etc.) that are capable of transferring the samples (e.g., well plates) from the sample source to other components of the sample preparation system 101 and / or to other systems, such as the ejection system 102 and / or the capture probe 105. As an example, the sample handler 80 may transfer a well plate from the sample preparation system 101 to the ejection system 102. More specifically, the sample handler 80 may transfer the well plate to a plate handler 95 of the ejection system 102. Accordingly, the sample preparation system 101 may also be referred to as a sample delivery system. In some examples, selected sample information (e.g. sample or compound ID, chemical structure of the target compound, or other sample information) could be obtained during the sample handling steps through the use of sample controller 82 and / or the sample handler 80, and communicated to the computing system 103 or the data processing system 400 thereof.

[0059] In addition to the plate handler 95, the ejection system 102 may include an ejector 90 that ejects droplets from the wells of the well plates. The ejector 90 may be any type of suitable ejector, such as an acoustic ejector, a pneumatic ejector, or other type of contactless ejector, or a contact sampler. In an example, the plate handler 95 receives a well plate from the sample handler 80. The plate handler 95 transports the plate to a capture location that may be aligned with the capture probe 105. Once in the capture location, the ejector 90 ejects droplets from one or more wells of the well plates. The plate handler 95 may include one or more electro-mechanical devices, such as a translation stage that translates the well plate in an x-y plane to align wells of the well plate with the ejector 90 and / or or the capture probe 105.

[0060] The computing system 103 includes computing resources, components, and modules that are operative to perform various functions including but not limited to: communicating with other subsystems, receiving and transmitting electrical signals with other subsystems or components thereof, receiving, responding to, and executing user instructions, performing calculations, processing raw data received from mass analyzer, performing splitting data, performing sample-dataset correlation, generating and analyzing mass spectrometry data, identifying, annotating, and assigning MS peaks of mass spectra, extracting spectral features from mass spectra, conducting library search, identifying analytes, and outputting analytical report to end users.

[0061] In some examples, the computing system 103 includes a computing device 200, a controller 135, and a data processing system 400. The computing device 200 may be in the form of electronic signal processors and operative to perform various computing functions. The controller 135 may be in the form of electronic signal processors and in electrical communication with other subsystems within the system 10 or 10’. The controller 135 is further configured to coordinate some or all of the operations of the pluralities of the various components of the system 10 or 10’. The data processing system 400 may include various components and modules operative to process mass spectrometry data and to provide real-time feedback to end users and other subsystems.

[0062] In some examples, a network 104 may be operably connected to any one or all of the subsystems or components in the system 10 or 10’. The network 104 is a communication network. In the example, the network 104 is a wireless local area network (WLAN). The network 104 may be any suitable type of network and / or a combination of networks. The network 104 may be wired or wireless and of any communication protocol. The network 104may include, without limitation, the Internet, a local area network (LAN), a wide area network (WAN), a wireless LAN (WLAN), a mesh network, a virtual private network (VPN), a cellular network, and / or any other network that allows system 104 to operate as described herein.

[0063] In some examples, the system 10 or 10’ may further include one or more library / database 106. The database 106 can be a commercial database, or a private database containing analytical information from previously analyzed samples, or a combination of both. The library / database 106 includes chemical knowledge of standard of known compounds stored therein, including but not limited to chemical formula or elemental composition, neutral mass, monoisotopic mass, or mass of internal fragments thereof. In some examples, the computer system 103 is operative to perform a search using the database 106 and / or to compare data produced by the data processing system 400 to the retrieved data from the database 106 (such as molecular mass information or spectral features) to facilitate mass analysis and / or analyte identification.

[0064] Also illustrated in FIG. 2 are components of a sample delivery system for use in combination with the mass analysis instrument 100. The sample delivery system includes at least a sample source 70 for supplying a plurality of samples, a sample handler 80 for delivering the plurality of samples to a capture location, and a capture probe 105 for independently capturing one or more samples of the plurality of samples. In some aspects, the sample delivery system may further include a stage 95 for locating each sample for the plurality of samples proximate to a capture surface of the capture probe 105 and an ejector 90 for selectively ejecting that located sample into the capture surface of the capture probe.

[0065] In operation, a sample delivery system (including sample source 70 and sample handler 80) can iteratively deliver independent samples from a plurality of samples (e.g., a sample from a well of a well plate 75) to the capture probe 105. The capture probe 105 can dilute and transport each such delivered sample to the ion source 115 disposed downstream of the capture probe 105 for ionizing the diluted sample. A mass analyzer 120 can receive generated ions from the ion source 115 for mass analysis. The mass analyzer 120 is operative to selectively separate ions of interest from generated ions received from the ion source 115 and to deliver the ions of interest to an ion detector 126 that generates a mass spectrometer signal indicative of detected ions to the data processing system 400. In some aspects, the separate ions of interest may be indicated in an analysis instruction associated with that sample. In some aspects, the separate ions of interest may be indicated in an analysis instruction identified by an indicia physically associated with the plurality of samples.

[0066] In some aspects, the system 10 or 10’ may further include the generation, assignment, and use of identifiers associated with collections of samples and / or individual samples, and incorporation by one or more of components 70, 80, 95, 105, 100, etc. of identifier readers. For instance, an identifier associated with a well plate may be read or scanned by a machine reading device 65 as it leaves the sample source 70 and / or when the well plate is received by the stage 95. In such aspects, the identifiers) may be used by the system to associate a corresponding one or more sets of instructions for use by the mass analysis instrument 100, 120 when analyzing transported sample droplets 125. In some aspects, the identifier may include an indicia physically associated with the plurality of samples. In some aspects, the indicia may be readable by optical, electrical, magnetic, or other non-contact reading means. Indicia or identifiers in accordance with such aspects of the disclosure can include any characters, symbols, or other devices suitable for use in adequately identifying samples, sample collections, and / or handling or analysis instructions suitable for use in implementing the various aspects and examples of the present disclosure.

[0067] Additional details regarding implementation and operation of system 10 or 10’ in accordance with various aspects and examples of the present disclosure can be explained with reference to the Figures. FIGS. 1 and 2 present system diagrams illustrating examples of a system 10 or 10’, each example including a sample handler 80 and an associated controller 135, which may be in operative communication with a mass analysis instrument 100 and a controller for the capture probe 105, which may include, for example, an a Sciex OS computer available from Sciex, or other control component. The Sciex OS computer includes a control component 107 for the capture probe 105, represented for example by Sciex open port probe (OPP) (also referred to as an open port interface (OPI)) software, and a control component 127 for the mass analysis instrument 100. The mass analysis instrument 100 and capture probe controller 107 may be further in operative communication with an ejector 90 and an X-Y Well Plate Stage 95 and plate handler controller 96, which may be, for example, a liquid droplet ejector with embedded computer or processor. For the purposes of this application, these distributed controller components may collectively be considered to be a system controller, and depending upon the configuration may be centralized, or distributed as is the case here. For instance, one of the controllers or controller components may send signals to the other controllers to control the respective devices.

[0068] FIG. 3 illustrates one example of a centralized control system 20 for controlling the operation of the system 10 or 10’, according to FIGS. 1 and 2. In the illustrated example, the centralized control system 20 includes the controllers for each subsystem of the system 10 or 10’, including 135, 82, 92, 96, 107, and 127. The controller 135 may be a controller for the mass analysis instrument 100 and may be used as the primary controller for controlling components in addition to those components housed within the mass analysis instrument 100. As such, the controller 135 may be considered the main or central controller that orchestrates, or communicates with, the other controllers to carry out the operations discussed herein in a more efficient manner.

[0069] Now referring to FIG. 4, an example of the computing device 200 according to FIGS. 1 and 2 is illustrated and described. It is noted that the computing system 103 of the system 10 or 10’ may include a single computing device 200 or may include a plurality of distributed computing devices 200 in operative communication with components of a mass analysis instrument 100. In the illustrated example of FIG. 4, the computing device(s) 200 may include a bus 202 or other communication mechanism of similar function for communicating information, and at least one processing element 204 coupled with bus 202 for processing information. As is appreciated by those skilled in the relevant arts, such at least one processing element 204 may include a plurality of processing elements or cores, which may be packaged as a single processor or in a distributed arrangement. Furthermore, in some examples, a plurality of virtual processing elements 204 may be included in the computing device 200 to provide the control or management operations for the mass analysis instrument 100.

[0070] Computing device 200 may also include one or more volatile memory(ies) 206, which can for example include random access memory(ies) (RAM) or other dynamic memory component(s), coupled to one or more busses 202 for use by the at least one processing element 204. Computing device 200 may further include static, non-volatile memory(ies) 208, such as read only memory (ROM) or other static memory components, coupled to busses 202 for storing information and instructions for use by the at least one processing element 204. A storage component 210, such as a storage disk or storage memory, may be provided for storing information and instructions for use by the at least one processing element 204. As is appreciated, in some examples the computing device 200 may include a distributed storage component 212, such as a networked disk or other storage resource available to the computing device 200.

[0071] Computing device 200 may be coupled to one or more displays 214 for displaying information to a computer user. Optional user input devices 216, such as a keyboard and / or touchscreen, may be coupled to a bus for communicating information and command selections to the at least one processing element 204. An optional graphical input device 218, such as a mouse, a trackball or cursor direction keys for communicating graphical user interface information and command selections to the at least one processing element. The computing device 200 may further include an input / output (I / O) component, such as a serial connection, digital connection, network connection, or other input / output component for allowing intercommunication with other computing components and the various components of the mass analysis instrument 100.

[0072] In various examples, computing device 200 can be connected to one or more other computer systems a network to form a networked system. Such networks can for example include one or more private networks, or public networks such as the Internet. In the networked system, one or more computer systems can store and serve the data to other computer systems. The one or more computer systems that store and serve the data can be referred to as servers or the cloud, in a cloud computing scenario. The one or more computer systems can include one or more web servers, for example. The other computer systems that send and receive data to and from the servers or the cloud can be referred to as client or cloud devices, for example. Various operations of the mass analysis instrument 100 may be supported by operation of the distributed computing systems.

[0073] Computing device 200 may be operative to control operation of the components of the mass analysis instrument 100 and the sample delivery components 70, 80, 95, 105 through controller(s) 135 and to handle data generated by components of the mass analysis instrument 100 through the data processing system 400. In some examples, analysis results are provided by computing device 200 in response to the at least one processing element 204 executing instructions contained in memory 206 or 208 and performing operations on data received from the mass analysis instrument 100. Execution of instructions contained in memory 206 or 208 by the at least one processing element 204 can render the mass analysis instrument 100 and associated sample delivery components operative to perform methods described herein. Alternatively, hard-wired circuitry may be used in place of or in combination with software instructions to implement the present teachings. Thus, implementations of the present teachings are not limited to any specific combination of hardware circuitry and software.

[0074] The term “computer-readable medium” as used herein refers to any media that participates in providing instructions to processor 204 for execution. Such a medium may take many forms, including but not limited to, non-volatile media, volatile media, and transmission media. Non-volatile media includes, for example, optical or magnetic disks, such as disk storage 210. Volatile media includes dynamic memory, such as memory 206. Transmission media includes coaxial cables, copper wire, and fiber optics, including the wires that include bus 202.

[0075] Common forms of computer-readable media or computer program products include, for example, a floppy disk, a flexible disk, hard disk, magnetic tape, or any other magnetic medium, a CD-ROM, digital video disc (DVD), a Blu-ray Disc, any other optical medium, a thumb drive, a memory card, a RAM, PROM, and EPROM, a FLASH-EPROM, any other memory chip or cartridge, or any other tangible medium from which a computer can read.

[0076] Various forms of computer readable media may be involved in carrying one or more sequences of one or more instructions to processor 204 for execution. For example, the instructions may initially be carried on the magnetic disk of a remote computer. The remote computer can load the instructions into its dynamic memory and send the instructions over a telephone line using a modem. A modem local to computer system 200 can receive the data on the telephone line and use an infra-red transmitter to convert the data to an infra-red signal. An infra-red detector coupled to bus 202 can receive the data carried in the infra-red signal and place the data on bus 202. Bus 202 carries the data to memory 206, from which processor 204 retrieves and executes the instructions. The instructions received by memory 206 may optionally be stored on storage device 210 either before or after execution by processor 204.

[0077] In accordance with various examples, instructions configured to be executed by a processor to perform a method are stored on a computer-readable medium. The computer-readable medium can be a device that stores digital information. For example, a computer-readable medium includes a compact disc read-only memory (CD-ROM) as is known in the art for storing software. The computer-readable medium is accessed by a processor suitable for executing instructions configured to be executed.

[0078] FIG. 5 depicts a schematic view of an example AEMS system 300 combining an acoustic droplet ejection (ADE) device 302 with an open port interface (OPI) 304 and an ESI device source 314. The system 300 provides an example of an integration and physical connection between the ejection system 102, the capture probe 105, and the mass analysis instrument 100.

[0079] The ADE 302 includes an acoustic ejector 306 that is configured to eject a droplet 308 from a reservoir 312 into the open end of a sample receiver such as, e.g., sampling OPI 304. The acoustic ejector 306 is one example of the ejector 90, and the sampling OPI 304 is one example of the capture probe 105. As shown in FIG. 5, the example system 300 generally includes the sampling OPI 304 in liquid communication with the ESI source 314 for discharging a liquid containing one or more sample analytes (e.g., via electrospray electrode 316) into an ionization chamber 318, and a mass analyzer detector (depicted generally at 320) in communication with the ionization chamber 318 for downstream processing and / or detection of ions generated by the ESI source 314. The ESI source 314 is an example of the ion source 115, and the mass analyzer detector 320 is an example of the ion detector 126.

[0080] Due to the configuration of the nebulizer probe 338 and electrospray electrode 316 of the ESI source 314, samples ejected therefrom are in the gas phase. A liquid handling system 322 (e.g., including one or more pumps 324 and one or more conduits 325) provides for the flow of a transport liquid from a solvent reservoir 326 to the sampling OPI 304 and from the sampling OPI 304 to the ESI source 314. The solvent reservoir 326 (e.g., containing a liquid, desorption solvent) can be liquidly coupled to the sampling OPI 304 via a supply conduit 327 through which the transport liquid can be delivered at a selected volumetric rate by the pump 324 (e.g., a reciprocating pump, a positive displacement pump such as a rotary, gear, plunger, piston, peristaltic, diaphragm pump, or other pump such as a gravity, impulse, pneumatic, electrokinetic, and centrifugal pump), all by way of non-limiting example. The flow of transport liquid into and out of the sampling OPI 304 occurs within a sample space accessible at the open end such that one or more droplets 308 can be introduced into the liquid boundary 328 at the sample tip and subsequently delivered to the ESI source 314. The ADE 302 is configured to generate acoustic energy that is applied to a liquid contained within a well or reservoir 310 of a well plate 312 that causes one or more droplets 308 to be ejected from the reservoir 310 into the open end of the sampling OPI 304. The well plate 312 is an example of the well plates 75 discussed above. The acoustic energy is generated from an acoustic ejector 306, which is an example of the ejector 90 discussed above. The well plate 312 may reside on a movable stage 334, which is an example of the plate stage 95 discussed above.

[0081] A controller 330 can be operatively coupled to the ADE 302 and can be configured to operate any aspect of the ADE 302 (e.g., focusing structures, acoustic ejector 306, automation elements for moving a movable stage 334 so as to position a reservoir 310 into alignment with the acoustic ejector 306 and / or the OPI 304, etc.). This enables the ADE 302 to eject droplets 308 into the sampling OPI 304 as otherwise discussed herein substantially continuously or for selected portions of an experimental protocol by way of non-limiting example. Controller 330 can be, but is not limited to, a microcontroller, a computer, a microprocessor, or any device capable of sending and receiving control signals and data. Wired or wireless connections between the controller 330 and the remaining elements of the system 300 are not depicted but would be apparent to a person of skill in the art. The controller 330 may be any of the controllers discussed above and may be responsible for controlling the mass analysis instrument 100 and / or the sample delivery system 101 as well.

[0082] As shown in FIG. 5, the ESI source 314 can include a source 336 of pressurized gas (e.g., nitrogen, air, or a noble gas) that supplies a high velocity nebulizing gas flow to the nebulizer probe 338 that surrounds the outlet end of the electrospray electrode 316. As depicted, the electrospray electrode 316 protrudes from a distal end of the nebulizer probe 338. The pressured gas interacts with the liquid discharged from the electrospray electrode 316 to enhance the formation of the sample plume and the ion release within the plume for sampling by mass analyzer detector 320, e.g., via the interaction of the high-speed nebulizing flow and jet of liquid sample. The liquid discharged may include discrete volumes of liquid samples LS received from each reservoir 310 of the well plate 312. Each received liquid sample LS is instantly diluted by a solvent after being captured within the OPI, with a dilution factor of about 1000 times (as flow of the solvent moves the liquid samples LS from the OPI 304 to the ESI source 314, the solvent is also referred to herein as the transport liquid). The nebulizer gas can be supplied at a variety of flow rates, for example, in a range from about 0.1 L / min to about 20 L / rnin, which can also be controlled under the influence of controller 330 (e.g., via opening and / or closing valve 340).

[0083] It is appreciated that the flow rate of the nebulizer gas can be adjusted (e.g., under the influence of controller 330) such that the flow rate of liquid within the sampling OPI 304 can be adjusted based, for example, on suction / aspiration force generated by the interaction of the nebulizer gas and the analyte-solvent dilution as it is being discharged from the electrospray electrode 316 (e.g., due to the Venturi effect). The ionization chamber 318 can be maintained at atmospheric pressure, though in some examples, the ionization chamber 318 can be evacuated to a pressure lower than atmospheric pressure.

[0084] Automatic data processing

[0085] As discussed above, the present systems may be operative to analyze a large collection of substance samples and generate a large quantity of mass spectrometry data in a high throughput fashion. For example, one sample per second, or more than 50,000 samples per day. Systems 10 or 10’ discussed above according to the present disclosure advantageously provides an auto-triggered data processing function to avoid potential issues arising from the assay throughput bottleneck, to maintain a constant workflow of operations, to perform data processing and acquisition with matched speed as sample analysis, and to improve the overall productivity of the system.

[0086] Background Processing for Identification of Covalent Binding

[0087] FIGS. 6A-6C are illustrations of mass spectra for protein-only samples and protein and ligand samples, in accordance with various examples of the present disclosure. In particular, FIG. 6A illustrates a deconvoluted zero-charge mass spectrum 600 that is reconstructed based on a trace mass-to-charge (m / z) spectrum that is typically extracted during MS measurements. FIG. 6A illustrates a plurality of peaks 602 indicative of a target molecule such as, e.g., a protein that is not combined with any ligand. Accordingly, peak 602 is indicative of the protein, and other peaks may be indicative of background noise that may be identified and subtracted from the main peak, as further discussed below.

[0088] FIG. 6B illustrates a deconvoluted zero-charge mass spectrum 605 for a control sample including the target molecule in the absence of any ligands in the control sample. The control sample may include, e.g., the target molecule such as, e.g., a protein, with a dimethyl sulfoxide (DMSO) solvent instead of a ligand, and thus permits the measurement of the peak intensity for a ligand-free target molecule, or a target molecule that is unbonded to the ligand. Peak 610 illustrated in FIG. 6B is located in the mass window wO of deconvoluted mass spectrum 605 that corresponds to the target molecule unbonded to any ligand, and has a signal intensity “P.” It should be noted that FIG. 6B also illustrates an intensity signal 620 which is indicative of a background noise, and the intensity signal 620 is located in the mass window wl of deconvoluted mass spectrum 605 that corresponds to a complex consisting of the target molecule bonded to one or more molecules of the ligand. The intensity signal 620 includes a background signal identified as “B” in FIG. 6B. Accordingly, even in the absence of a ligand in the control sample, a background signal “B” may be detected at a mass window on the deconvoluted mass spectrum that corresponds to the sum of the target molecule and the one or more molecules of ligand. The appearance of the background signal “B” in the control sample which does not include the ligand at the mass window wl may be due the existence of artifacts or remnants of the ligand present in the sample well. Signal intensity 625 in FIG. 6B at mass window w2 is illustrative of another background signal, corresponding to the sum of the mass of the target molecule and additional molecules of the ligand, or the sum of the mass of the target molecule and the mass of a different ligand. For example, if 620 is the background signal of the target molecule and a single ligand molecule, 625 may be the background signal of the target molecule and two ligand molecules. In the x-axis of a deconvoluted mass spectrum, the heavier molecular complex shows a signal, e.g., at mass window w2, which is to the right, i.e., heavier, of the lighter molecular complex, e.g., at mass window wl. The background intensities “B” in 620 and 625 may be different from one another, or may be the same.

[0089] FIG. 6C illustrates a deconvoluted zero-charge mass spectrum 615 for a sample including the target molecule and at least a ligand. In mass spectrum 615, the peak 630 represents the signal intensity at the mass window wO of the target molecule unbonded to any ligand, with a signal intensity “Pi,” where “i” is indicative of the ligand present in the sample, and the peak 640 represents the signal intensity at the mass window wl corresponding to the target molecule and the ligand together in the sample. The signal intensity “PLobs” indicates for the observed peak intensity of the target molecule together with the ligand. The signal intensity PLobs is the sum of the background intensity Bi of the second sample and the background-subtracted signal PLi of the second sample, the signal PLi being the signal intensity of the target molecule together with the ligand without the background signal. The mass window wO of peak 630 in spectrum 615 is the same as the mass window wO of peak 610 in spectrum 605 because both peaks represent the unbonded target molecule, and the mass window wO corresponds to the molecular mass of the target molecule. For example, the background intensity B in FIG. 6B and the background intensity Bi in FIG. 6C are in a mass window of the deconvoluted mass spectrum that corresponds to a sum of the molecular mass of the ligand and the molecular mass of the target molecule. For example, the mass window wl corresponds to a single molecule of ligand and a single molecule of the target protein. There may be other peaks, at higher mass windows (not shown), that correspond to the sum of the molecular mass of the target molecule and the mass of two or more molecules of the ligand combined therewith.

[0090] Based on the signal intensities 610, 620, 625, 630 and 640 illustrated in FIGS. 6B and 6C, the intensity Pi at the mass window wO of the target protein, as well as the intensity PLi at the mass windows wl or w2 of the target molecule combined with one or more molecules of ligand, may be extracted, and signal intensity ratios Ri for each combination of (target molecule + ligand “i”) / (target molecule) may be calculated. For example, if there are 1500 ligands to be screened in a plate, there may be 1500 ratios Ri to be determined, one ratio for each ligand. When the target molecule is bonded to multiple molecules of the same ligand “i,” and the number of molecules is “k,” then multiple “k” values of the ratio Ri,k may be calculated for each ligand “i,” as further discussed below.

[0091] Target molecule bonded to a single ligand

[0092] In the deconvoluted mass spectrum 615, the signal contribution from the background at the mass window wl of the target molecule bonded to the ligand (i.e., target molecule + ligand), referred to herein as target molecule-ligand “i” combination, may be subtracted from the observed signal at the same mass window wl for a more accurate determination of the level of covalent binding of the target molecule-ligand “i” combination. Referring to FIG. 6B, an intensity ratio R may be determined as the ratio between the intensity “B” of the background in mass window wl in the absence of any ligand in the sample, over the signal intensity “Pb” of the ligand-free or protein-only target molecule in the sample. Accordingly, the intensity ratio Ri for a control sample, illustrated in FIG. 6B, may be determined according to Equation (1) below:

[0093] Ri = B / Pb (1). Ri is specific to the mass of ligand “i” because it corresponds to the mass window of the protein combined with the given ligand. When a given ligand “i” is present and is bonded to the target molecule, then the background may be referred to as Bi and the intensity ratio is the same intensity ratio Ri calculated in Equation (1) above. Accordingly, the intensity ratio Ri for a bonded target molecule, illustrated in FIG. 6C, may also be calculated according to Equation (2) below:

[0094] Ri = Bi / (Pi+PLi) (2).

[0095] PLi in Equation (2) refers to the background-subtracted signal intensity attributable to the target molecule-ligand “i” combination of peak 640 at mass window wl, and “Pi” at peak 630 is the signal intensity attributable to the target moleculeligand “i” combination at the mass window wO corresponding to the mass of only the target molecule, as illustrated in FIG. 6C. The observed signal intensity PLobs,i at mass window wl is the signal intensity that is observed, e.g., measured by the analysis device, and includes both the background-subtracted signal intensity PLi and the background signal intensity Bi of the target molecule-ligand “i” combination. For example, if the signal intensity at mass window wO is Pi, and the observed signal intensity at mass window wl is PLobs,i, then the signal intensity PLi of the background-subtracted signal intensity of the target molecule-ligand “i” combination may be calculated according to Equation (3) below:

[0096] PLi = PLobs,i - Bi (3).

[0097] In equating both expressions of the intensity ratio Ri expressed above in Equations (1) and (2), it may be possible to determine the background-subtracted signal intensity PLi of the target molecule bonded to ligand i according to Equation (4) below:

[0098] PLi = (PLobs,i - RiPi) / (1+Ri) (4).

[0099] An alternative and more simplified version of Equation (4), when the Ri value is sufficiently small, is given in Equation (5) below:

[0100] PLi = PLobs,i - RiPi (5).

[0101] Target molecule bonded to “k” molecules of ligand “i”

[0102] When more than one molecule of ligand is bonded to the target molecule, e.g., “k” molecules, a background may appear at mass windows corresponding to the sums of the target molecule and the masses of the ligand molecules. For example, as illustrated in FIG. 6B, when a second molecule (k = 2) of the same ligand “i” is bonded to the target molecule, then a background signal may appear at the mass window w2 corresponding to the sum of the mass of the target protein and two (2) molecules of ligand, even in the spectrum of the ligand-free target molecule. An intensity ratio Rik may be calculated for each mass window for each of the two ligand molecules, e.g., intensity ratios Ril and Ri2. For example, if there are up to 3 ligand molecules, then up to 3 background signals Bik may be measured at 3 mass windows wl, w2 and w3 corresponding to the sums of the mass of the target molecule and the masses of 1, 2 or 3 ligands, respectively. Thus, up to 3 intensity ratios Rik may be calculated, e.g., Ril, Ri2 and Ri3. Each intensity ratio Ril, Ri2 and Ri3 is a respective ratio of the intensity of the background Bik at the corresponding mass window wk of the target molecule combined with a single molecule of ligand “i” (Ril), the target molecule combined with two molecules of ligand “i” (Ri2), and the target molecule combined with three molecules of ligand “i” (Ri3). Although three molecules of ligand as described herein, there may be more or less than three ligand molecules combined with the target molecule in the sample. The value of “k” may range from 1 to 5, but may be higher than 5.

[0103] In order to determine whether the target molecule is covalently bonded to any molecule of ligand i, equations similar to Equations ( l)-(4) above and which correspond to a same ligand “i” may be derived for a number “k” of molecules of ligand “i” combined with the target molecule. Accordingly, the intensity ratio Rik of the k molecules of ligand “i” combined with the target molecule may be calculated according to Equation (6) below:

[0104] Rik=Bik / (Pi+ PLik) (k=l, 2, 3,.. .) (6).

[0105] In Equation (6), Rik is the intensity ratio of the k molecules of ligand “i” combined with the target molecule, Bik is the background intensity of the target molecule bonded to “k” molecules of ligand “i” measured at a mass window wk on the deconvoluted mass spectrum, Pi is the signal intensity at the mass window of the unbonded target molecule, and PLik is the background-subtracted signal intensity of the target molecule bonded to “k” molecules of ligand “i”. In the example illustrated in FIG. 6B, k = 2, and Ri2 is the ratio intensity at mass window w2. Ril is the ratio intensity at mass window wl .

[0106] Similarly to Equation (3) above, the background-subtracted signal intensity PLik of the target molecule bonded to “k” molecules of the ligand “i” at the mass window wk may be determined according to Equation (7) below:

[0107] PLik = PLobs,ik - Bik, where k = 1 , 2, 3.. . (7). Similarly to Equations (4) and (5) above, the background-subtracted signal intensity PLi of the target molecule bonded to “k” molecules of the ligand “i” may be determined according to one of Equations (8) and (9) below:

[0108] PLik = (PLobs,ik - RikPi) / (l+Rik) (8).

[0109] PLik = PLobs,ik - RikPi (9).

[0110] When the background-subtracted signal intensity PLik is calculated based on the above equations, it is then possible to determine whether the target molecule is covalently bonded to “k” molecules of ligand “i” by calculating the ratio of the background-subtracted signal intensity PLik to the signal intensity of the unbonded target molecule Pi, and comparing this ratio to a threshold. For example, if the ratio PLik / Pi is greater than a threshold in the range of 10% to 30%, depending on the molecular properties of ligand “i,” then it may be determined that the target molecule is covalently bonded to “k” molecules of ligand “i”. If the ratio PLik / Pi is lower than the threshold, then it may be determined that the target molecule is not covalently bonded to “k” molecules of ligand “i.”

[0111] For the same target molecule and the same ligand, the ratio PLik / Pi may be over the threshold for some values of k, e.g., low values such as k=l, and may be below the threshold for other valuers of k, e.g., higher values such as k=3. In this case, it may be concluded that the target molecule is covalently bonded to a single molecule of the ligand “i” but is not covalently bonded to three (3) molecules of the ligand “i”. When the ratio PLik / Pi is non-negligible for more than one molecule of ligand, it may be determined that the ligand has multiple possible binding sites on the target molecule. As a result, the target molecule may not be a specific drug and may have unwanted side effects.

[0112] FIG. 7 represents a flowchart illustrating a method for automatic background processing of a deconvoluted mass spectrum, in accordance with various examples of the disclosure. Operation 710 includes ionizing a first sample and a second sample. The first sample may be a sample that includes an unbonded target molecule, e.g., a target molecule or protein not combined with any ligand in the first sample, and the second sample may be the same target molecule but with a ligand combined thereto. Ionizing the samples may include using an ionization device such as, e.g., a desorption electrospray ionization (DESI) device, a matrix-assisted laser desorption ionization (MALDI) device, a liquid-atmospheric pressure (LAP)-MALDI device, a rapid-fire mass spectrometer, a pneumatic electrospray ionization (ESI) device, and an electron ionization (El) device.

[0113] Operation 720 includes capturing a raw mass spectra for the ionized first sample and for the ionized second sample. The raw mass spectra for the ionized first and second samples may be captured by a mass analysis instrument such as, e.g., a differential mobility spectrometer (DMS), a mass spectrometer (MS), or a DMS / MS. The mass analysis instrument may include a capture device or probe that captures the sample and provides the sample to other components of the mass capture and analysis system to generate raw mass spectra. For example, the captured raw mass spectra for a given sample may include the measurement of the signal intensity with respect to the mass-to-charge ratio (m / z) of the sample for a series of known charges.

[0114] Operation 730 includes generating a deconvoluted mass spectrum for each of the first sample and the second sample, where the deconvoluted mass spectrum typically describes the measured signal intensity with respect to total mass of the molecular compound, and may be derived based on the captured raw mass spectrum. For example, as the raw mass spectra typically describe the measured signal intensity with respect to a mass-to-charge ratio (m / z), generating the deconvoluted mass spectrum may be achieved by, e.g., deriving the total mass based on the mass-to-charge ratios and their corresponding charges. Accordingly, the generated deconvoluted mass spectra describe a signal intensity in the y-axis or ordinate with respect to a mass of the compound in the x-axis or abscissa. An example of a deconvoluted mass spectrum is provided in the spectrum 600 illustrated in FIG. 6A and described above.

[0115] Operation 740 includes determining an intensity ratio R of the first sample. The intensity ratio R of the first sample may be defined as the ratio of the background intensity B at the mass window of the deconvoluted mass spectrum that corresponds to the sum of the mass of the target molecule and the mass of the ligand in the first sample to the signal intensity P at the mass window corresponding to the target molecule in the first sample. With reference to FIG. 6B, the signal intensity of the target molecule in the first sample is illustrated by peak 610 at mass window wO, and the background intensity B in the first sample is illustrated by 620 at mass window wl . It is to be noted that even in the first sample which does not include the ligand, a background signal B at mass window wl corresponding to the combination of the target molecule and the ligand may be detected, as illustrated by 620 or 625. The intensity ratio R is calculated according to Equation (1) discussed above. Operation 750 includes determining the background intensity corresponding to the combination of the target molecule and the ligand “i” in the second sample, referred to herein as “Bi.” As illustrated in Equation (2) above, the intensity ratio Ri is equal to the ratio of the background intensity Bi of the bonded target molecule in the second sample to the sum of the signal intensities of the target molecule Pi and of the ligand in the second sample PLi. Accordingly, the intensity ratio is expressed as in Equation (2) above. Based on Equations (1) and (2) above, which implies that B / P = Bi / (Pi+PLi), Bi can be determined according to Equation (10) below:

[0116] Bi = Ri x (Pi+PLi) (10).

[0117] Operation 760 includes determining the background-subtracted signal intensity PLi for the target molecule-ligand “i” combination in the second sample. Accordingly, operation 760 may include determining the observed signal intensity “PLobs,i” of the target molecule-ligand “i” combination in the second sample from the deconvoluted mass spectrum such as spectrum 615 illustrated in FIG. 6C, and subtracting the background signal Bi therefrom. The observed signal intensity “PLobs,i” may be, e.g., the observed peak 640 illustrated in FIG. 6C located at window wl indicative of the target molecule-ligand “i” combination, and the background intensity Bi may be nestled in the same mass window wl. When the intensity “PLobs,i” is determined, then the background-subtracted intensity PLi may be determined by subtracting the background intensity Bi therefrom as indicated in Equation (3) above. Because Bi is itself a function of PLi, as indicated in Equation (10), combining Equations (3) and (10) allows to determine PLi as being equal to (PLobs,i - RiPi) / (l+Ri), as indicated in equation (4) above. In some examples, when Ri is sufficiently small, then PLi may be calculated as being equal to PLobs,i - RiPi, as indicated in equation (5) above.

[0118] In the case of multiple ligands “i” and multiple molecules “k” of each ligand “i” being combined with the target molecule, then the intensity ratio Rik for each ligand “i” may be calculated based on Equation (6) above. The background-subtracted signal intensity PLik of the target molecule bonded to a “k” number of molecules of ligand “i” may be determined according to Equation (7). By combining Equations (6) and (7), the intensity PLik of the target molecule bonded to a “k” number of molecules of ligand “i” may be determined according to any one of Equations (8) and (9) above.

[0119] When k = 3, then the background-subtracted signal intensity PLik the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively may be calculated according to the following equations ( 11 )-( 13) :

[0120] PLil = (PLobsil*(l+Ri2+Ri3) - Ril(PLobs,i2 + PLobs,i3+Pi)) / (l+Ril+Ri2+Ri3) (11); PLi2 = (PLobsi2*(l+Ril+Ri3) - Ri2(PLobs,il + PLobs,i3+Pi)) / (l+Ril+Ri2+Ri3) (12); and

[0121] PLi3 = (PLobs,i3*(l+Ril+Ri2) - R3(PLobs,il + PLobs,i2+Pi)) / (l+Ril+Ri2+Ri3) (13).

[0122] In Equations (11)-(13), PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively, PLobsi,l, PLobsi,2 and PLobsi,3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i” , respectively, Pi is a signal intensity of the target molecule, and Ril, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively.

[0123] Alternatively, also when k = 3, then the background-subtracted signal intensity PLik of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively may also be calculated according to the following equations (14)-(16):

[0124] PLil = PLobs,il - Ril(PLobsi,2 + PLobsi,3+Pi) (14)

[0125] PLi2 = PLobs,i2 - Ri2(PLobsi,l + PLobsi,3+Pi) (15); and

[0126] PLi3 = PLobs,i3 - Ri3(PLobsi,l + PLobsi,2+Pi) (16).

[0127] In Equations ( 14)-(16), PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively, PLobsi,l, PLobsi,2 and PLobsi,3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively, Pi is a signal intensity of the target molecule, and Ril, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively.

[0128] Operation 770 includes determining a level of covalent bonding of the ligand, or of a number of molecules of ligand, to the target molecule based on the background- subtracted intensity signal PLi at the mass window corresponding to the combination of the target molecule and one or more molecules of ligand, e.g., mass window wl in FIG. 6C, and the intensity signal Pi at the mass window corresponding to the target molecule, e.g., mass window wO. For example, operation 770 includes determining the ratio of PLi / Pi, and comparing the ratio PLi / Pi to a threshold. The threshold may be in a range of 10% to 30%. Based on the comparison, operation 770 includes determining whether the ligand and the target molecule are covalently bonded to each other. In some embodiments, operation 770 includes a percentage adduct PLi / (PLi + Pi) determination and operation 770 compares the percentage adduct to an adduct percentage threshold. The ratio PLi / Pi and the percentage adduct and any associated threshold values can be interconverted where % adduct = l / ( 1+Pi / PLi). As can be appreciated, this ratio and / or adduct can be converted into other values by adding, subtracting, multiplying and / or dividing by other variables and / or constants and comparing the value to a corresponding threshold that has been calculated by performing the same adding, subtracting, multiplying and / or division by other variables and / or constants. In one example a PLi / Pi ratio of 10% corresponds to an adduct percentage threshold of 1 / 11 x 100% and a threshold ratio of 30% corresponds to an adduct percentage threshold of 3 / 13 x 100%.

[0129] For example, if the ratio PLi / Pi is greater than the threshold, then it may be concluded that the ligand and the target molecule are covalently bonded. Conversely, if the ratio PLi / Pi is less than the threshold, then it may be concluded that the ligand and the target molecule are not covalently bonded. In the case of several molecules of ligand, each molecule having a specific PLi, then for a same target molecule, it may be determined whether the target molecule may be covalently bonded to a single ligand molecule, to two ligand molecules, or to more. For example, based on the ratio PLi / Pi discussed above, it may be determined that the target molecule is covalently bonded to a single molecule of ligand because the ratio PLi 1 / Pi is greater than the threshold, but that the target molecule is not covalently bonded to two ligand molecules because the ratio PLi2 / Pi is below the threshold. Thus, the calculation of the above ratio allows the determination of the existence or absence of covalent bonding between a same target molecule, e.g., a protein, and one, two, three or more ligand molecules.

[0130] Although some aspects have been described in the context of an apparatus, it is clear that these aspects also represent a description of the corresponding method, where a block or device corresponds to a method step or a feature of a method step. Analogously, aspects described in the context of a method step also represent a description of a corresponding block or item or feature of a corresponding apparatus. Some or all of the method steps may be executed by (or using) a hardware apparatus, like for example, a processor, a microprocessor, a programmable computer, or an electronic circuit. In some examples, some one or more of the most important method steps may be executed by such an apparatus.

[0131] Generally, examples of the present disclosure can be implemented through the use of computer program products with program codes, the program codes being operative for performing the operations described herein when the computer program product runs on a computer such as may be used to embody any or all of controllers such as, 135, 82, 92, 96, 107, 127, or 330.

[0132] Although various examples and examples are described herein, those of ordinary skill in the art will understand that many modifications may be made thereto within the scope of the present disclosure. Accordingly, it is not intended that the scope of the disclosure in any way be limited by the examples provided.

Claims

CLAIMSWhat is claimed is:

1. A method for background processing of a deconvoluted mass spectrum for a collection of samples, the method comprising: ionizing a first sample and a second sample of a same target molecule, the first sample comprising the target molecule in the absence of a ligand “i”, and the second sample comprising a target molecule-ligand “i” combination; capturing a raw mass spectrum for each of the ionized first sample and the ionized second sample; generating a deconvoluted mass spectrum for each of the first sample and the second sample based on their respective captured raw mass spectrum; determining, based on the generated deconvoluted mass spectrum of the first sample, an intensity ratio R of a background intensity B at a mass window of the deconvoluted mass spectrum corresponding to a sum of a mass of the target molecule and a mass of the ligand “i” in the first sample to a signal intensity P at a mass window corresponding to the target molecule in the first sample; and determining, based on the determined intensity ratio R, a background intensity Bi of the target molecule-ligand “i” combination in the deconvoluted mass spectrum of the second sample at a mass window corresponding to the mass of the target moleculeligand “i” combination.

2. The method of claim 1, wherein the determined intensity ratio R of the first sample is equal to a ratio of the background intensity Bi to a sum of the signal intensity Pi at the mass window corresponding to the target molecule in the second sample and a signal intensity PLi of the target molecule-ligand “i” combination at the mass window corresponding to the sum of the mass of the target molecule and the mass of the ligand in the second sample.

3. The method of claim 2, wherein B / P = Bi / (Pi+PLi).

4. The method of claim 2 or claim 3, further comprising determining, based on the determined background intensity Bi of the second sample, the background-subtracted signal intensity PLi of the target molecule-ligand “i” combination in the second sample.

5. The method of claim 4, wherein determining the background-subtracted signal intensity PLi comprises: determining an observed signal intensity PLobs,i of the target molecule-ligand “i” combination in the second sample; and subtracting the determined background intensity Bi from the observed signal intensity PLobs,i.

6. The method of claim 5, wherein the signal intensity PLi is equal to PLi = (PLobs,i - Ri*Pi) / (l+Ri).

7. The method of any one of claims 4-6, further comprising: comparing a ratio PLi / Pi to a threshold; and based on the comparison, determining whether the ligand and the target molecule are covalently bonded.

8. The method of claim 7, wherein the threshold is in a range of 10% to 30%.

9. The method of any one of claims 5-8, wherein the signal intensity PLi of the ligand “i” in the second sample is equal to PLi = (PLobs,i - RiPi).

10. The method of claim 9, further comprising: comparing a ratio PLi / Pi to a threshold; and based on the comparison, determining whether the ligand and the target molecule are covalently bonded.

11. The method of any one of claims 1-10, wherein the second sample comprises the target molecule bonded to “k” molecules of the ligand “i”.

12. The method of claim 11, wherein a signal intensity PLik of “k” molecules of ligand “i” combined with the target molecule in the second sample is equal to PLik =(PLobs,ik - RikPi) / (l+Rik); where PLobs,ik is an observed signal intensity of “k” molecules of ligand “i” combined with the target molecule in the second sample, Pi is a signal intensity of the target molecule in the second sample, and Rik is an intensity ratio for ligand “i” in the second sample.

13. The method of claim 11 or claim 12, wherein a signal intensity PLik of “k” molecules of ligand “i” combined with the target molecule in the second sample is equal to PLik = (PLobs,ik - RikPi); where PLobs,ik is an observed signal intensity of “k” molecules of ligand “i” combined with the target molecule in the second sample, Pi is a signal intensity of the target molecule in the second sample, and Rik is an intensity ratio for ligand “i” in the second sample.

14. The method of any one of claims 11-13, wherein k is in a range of 1 to 5.

15. The method of any one of claims 11-14, wherein when k is equal to 3, intensity signals of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively are calculated as:PLil = (PLobsil*(l+Ri2+Ri3) - Ril(PLobs,i2 + PLobs,i3+Pi)) / (l+Ril+Ri2+Ri3);PLi2 = (PLobsi2*(l+Ril+Ri3) - Ri2(PLobs,il + PLobs,i3+Pi)) / (l+Ril+Ri2+Ri3); andPLi3 = (PLobs,i3*(l+Ril+Ri2) - R3(PLobs,il + PLobs,i2+Pi)) / (l+Ril+Ri2+Ri3); wherein:PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively;PLobsi,l, PLobsi,2 and PLobsi,3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i” , respectively;Pi is a signal intensity of the target molecule; andRil, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively.

16. The method of any one of claims 11-15, wherein when k is equal to 3, the intensity signals of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively, are calculated as:PLil = PLobs,il - Ril(PLobsi,2 + PLobsi,3+Pi);PLi2 = PLobs,i2 - Ri2(PLobsi,l + PLobsi,3+Pi); andPLi3 = PLobs,i3 - Ri3(PLobsi,l + PLobsi,2+Pi); wherein:PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively;PLobsi,l, PLobsi,2 and PLobsi,3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively;Pi is a signal intensity of the target molecule; andRil, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively.

17. The method of claim 16, further comprising: comparing PLi,k / Pi to a threshold; and based on the comparison, determining whether the k molecules of ligand “i” and the target molecule are covalently bonded.

18. The method of any one of claims 1-17, wherein the target molecule comprises one of a protein, an enzyme, and a nucleic acid.

19. A sample analyzing system comprising: a sample ionization device; a sample receiver; a mass analysis device fluidically coupled to the sample receiver and to the sample ionization device; a processor operatively coupled to the sample receiver, the sample ionization device and to the mass analysis device; anda memory coupled to the processor, the memory storing instructions that, when executed by the processor, performs a set of operations comprising: ionizing, via the sample ionization device, a first sample and a second sample of a same target molecule, the first sample comprising the target molecule in the absence of a ligand “i”, and the second sample comprising a target molecule-ligand “i” combination; capturing, via the mass analysis device, a raw mass spectrum for each of the ionized first sample and the ionized second sample; generating, via the processor, a deconvoluted mass spectrum for each of the first sample and the second sample based on their respective captured raw mass spectrum; determining, via the processor, based on the generated deconvoluted mass spectrum of the first sample, an intensity ratio R of a background intensity B at a mass window of the deconvoluted mass spectrum corresponding to a sum of a mass of the target molecule and a mass of the ligand “i” in the first sample to a signal intensity P at a mass window corresponding to the target molecule in the first sample; and determining, via the processor, based on the determined intensity ratio R, a background intensity Bi of the target molecule-ligand “i” combination in the deconvoluted mass spectrum of the second sample at a mass window corresponding to the mass of the target molecule-ligand “i” combination.

20. The system of claim 19, wherein the determined intensity ratio R of the first sample is equal to a ratio of the background intensity Bi to a sum of the signal intensity Pi at the mass window corresponding to the target molecule in the second sample and a signal intensity PLi of the target molecule-ligand “i” combination at the mass window corresponding to the sum of the mass of the target molecule and the mass of the ligand in the second sample.

21. The system of claim 20, wherein B / P = Bi / (Pi+PLi).

22. The system of claim 20 or claim 21, wherein the set of instructions further comprises determining, based on the determined background intensity Bi of the secondsample, the background-subtracted signal intensity PLi of the target molecule-ligand “i” combination in the second sample.

23. The system of claim 22, wherein the set of instructions further comprises determining the background-subtracted signal intensity PLi by: determining an observed signal intensity PLobs,i of the target molecule-ligand “i” combination in the second sample; and subtracting the determined background intensity Bi from the observed signal intensity PLobs,i.

24. The system of claim 23, wherein the signal intensity PLi is equal to PLi = (PLobs,i - Ri*Pi) / (l+Ri).

25. The system of claim 23 or claim 24, wherein the set of instructions further comprises: comparing a ratio PLi / Pi to a threshold; and based on the comparison, determining whether the ligand and the target molecule are covalently bonded.

26. The system of claim 25, wherein the threshold is in a range of 10% to 30%.

27. The system of any one of claims 23-26, wherein the signal intensity PLi of the ligand “i” in the second sample is equal to PLi = (PLobs,i - RiPi).

28. The system of claim 27, wherein the set of instructions further comprises: comparing a ratio PLi / Pi to a threshold; and based on the comparison, determining whether the ligand and the target molecule are covalently bonded.

29. The system of any one of claims 19-28, wherein the second sample comprises the target molecule bonded to “k” molecules of the ligand “i”.

30. The system of claim 29, wherein a signal intensity PLik of “k” molecules of ligand “i” combined with the target molecule in the second sample is equal to PLik =(PLobs,ik - RikPi) / (l+Rik); where PLobs,ik is an observed signal intensity of “k” molecules of ligand “i” combined with the target molecule in the second sample, Pi is a signal intensity of the target molecule in the second sample, and Rik is an intensity ratio for ligand “i” in the second sample.

31. The system of claim 29 or claim 30, wherein a signal intensity PLik of “k” molecules of ligand “i” combined with the target molecule in the second sample is equal to PLik = (PLobs,ik - RikPi); where PLobs,ik is an observed signal intensity of “k” molecules of ligand “i” combined with the target molecule in the second sample, Pi is a signal intensity of the target molecule in the second sample, and Rik is an intensity ratio for ligand “i” in the second sample.

32. The system of any one of claims 29-31, wherein when k is equal to 3, intensity signals of each combination of target molecule and ligand are calculated as:PLil = (PLobs,il*(l+Ri2+Ri3) - Ril(PLobs,i2 + PLobs,i3+P)) / ( 1 +Ri 1+Ri2+Ri3);PLi2 = (PLobs,i2*(l+Ril+Ri3) - Ri2(PLobs,il + PLobs,i3+P)) / (l+Ril+Ri2+Ri3); andPLi3 = (PLobs,i3*(l+Ril+Ri2) - Ri3(PLobs,il +PLobs,i2+P)) / ( 1 +Ri 1+Ri2+Ri3); wherein:PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively;PLobs,il, PLobs,i2 and PLobs,i3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively;Pi is a signal intensity of the target molecule; andRil, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively.

33. The system of any one of claims 29-32, wherein when k is equal to 3, the intensity signals the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i,” respectively, are calculated as:PLil = PLobs,il - Ril(PLobs,i2 + PLobs,i3+Pi);PLi2 = PLobs,i2 - Ri2(PLobs,il + PLobs,i3+iP); andPLi3 = PLobs,i3 - Ri3(PLobs,il + PLobs,i2+Pi); wherein:PLil, PLi2 and PLi3 are signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively;PLobs,il, PLobs,i2 and PLobs,i3 are observed signal intensities of the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively;Pi is a signal intensity of the target molecule; andRil, Ri2 and Ri3 are intensity ratios for the target molecule combined with one ligand molecule, two ligand molecules, and three ligand molecules of ligand “i”, respectively.

34. The system of claim 33, wherein the set of instructions further comprises: comparing PLi,k / Pi to a threshold; and based on the comparison, determining whether the kth molecule of ligand “i” and the target molecule are covalently bonded.

35. The system of any one of claims 19-34, wherein: the sample source is a well plate that comprises a plurality of wells; and each sample is in one of the plurality of wells.

36. The system of any one of claims 19-35, wherein the mass analysis device comprises at least one of a differential mobility spectrometer (DMS), a mass spectrometer (MS), and a DMS / MS.

37. The system of any one of claims 19-36, wherein the sample ionization device comprises one of a DESI device, a MALDI device, a LAP-MALDI device, a rapid-fire mass spectrometer, a pneumatic ESI device, and an El device.

Citation Information

Patent Citations

  • Collision cell for mass spectrometer

    US7923681B2

  • Acid-mediated assay for analyzing ligand-drug conjugates

    US20200363425A1